BioSpace News Archive

Toronto, Ontario--(Newsfile Corp. - January 7, 2021) - American Aires Inc. (CSE: WIFI) (the “Company” or “Aires”) has received approval from the Depository Trust Company to make its common shares, traded on the OTCQB under the symbol AAIRF, now eligible for electronic clearing and settlement through DTC’s automated processes.

Vancouver, British Columbia--(Newsfile Corp. - January 7, 2021) - Izotropic Corporation (CSE: IZO) (OTC Pink: IZOZF) (FSE: 1R3) (“Izotropic” or the “Company”) is pleased to announce the addition of Jeff Siewerdsen Ph.D. to the Company’s Scientific Advisory Board, comprised of industry experts and authorities in their respective fields.

Vancouver, British Columbia--(Newsfile Corp. - January 7, 2021) - Driven by the high demand in Israel, BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) reports that its Q4 sales orders for VINIA®, the Company’s proprietary red grape cell dietary supplement and functional food, have exceeded the earlier Q4 sales order forecast for the quarter.

-- 174,000-square-foot commercial GMP facility in Durham, NC for the manufacturing of ADVM-022, an intravitreal gene therapy in development for wet AMD and DME -- -- Multiple production suites with total capacity of 4000L, with further expansion opportunities -- -- Adverum to invest over $80M to be production-ready by end of 2023 and create more than 200 life sciences jobs; Company to receive state and local incentives of up to $9M --

Mirion Technologies, Inc., a global provider of innovative radiation detection and measurement solutions, is pleased to announce that it has acquired Sun Nuclear Corporation. Sun Nuclear is the global leader in Radiation Oncology Quality Assurance, delivering Patient Safety solutions for Diagnostic Imaging and Radiation Therapy c

Elucida Oncology, a biotechnology company pioneering the next frontier in targeted cancer therapy, announced today that Geno Germano, CEO and President of Elucida Oncology, will present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 11:35 a.m. EST.

Integral Molecular and Optimeos Life Sciences have partnered to develop antibody therapeutics using long-acting, sustained delivery formulations that will improve patient care and quality of life

Microbot Medical Inc. (Nasdaq: MBOT), announced that Harel Gadot, CEO, President and Chief Executive Officer, will be presenting virtually at two upcoming investor conferences.

Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics ® and Triclonics™) for cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Zenocutuzumab (Zeno) for the treatment of patients with metastatic solid tumors harboring NRG1 gene fusions (NRG1+ cancers) that have progressed on

The double-blind, placebo-controlled investigator-initiated CYstic fibrosis PHage study at Yale (CYPHY) will assess the safety and efficacy of phage therapy YPT-01 against chronic Pseudomonas aeruginosa infections